Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
和譽附屬抑制劑與艾力斯藥物開展聯合治療肺癌臨床研究

2024-05-09T  
和譽-B附屬治療肝細胞癌藥物獲美國授予孤兒藥認定

2024-04-25T  
和譽-B附屬在美國癌症研究協會年會上展示3項臨床前研究成果

2024-04-10T  
和譽-B附屬公司完成腱鞘巨細胞瘤臨床研究患者入組給藥

2024-04-09T  
和譽-B擬斥1億元回購股份

2024-03-13T  
《公司業績》和譽-B全年虧損收窄至4.32億元人民幣

2024-03-13T  
和譽-B附屬披露治療實體瘤藥物首次人體臨床試驗初步結果

2024-02-28T  
和譽-B針對非小細胞肺癌抑制劑臨床試驗完成首例患者給藥

2024-02-23T  
和譽-B收到默克對Pimicotinib獨家許可協議首付款7,000萬美元

2024-02-06T  
和譽-B附屬治療腱鞘巨細胞瘤藥物獲歐洲授予孤兒藥資格認定

2024-01-09T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.